DHEA: The Hormone That Peaks at 25 and Declines for Decades — What the Evidence Shows
DHEA: The Hormone That Peaks at 25 and Declines for Decades — What the Evidence Shows
Longevity

DHEA: The Hormone That Peaks at 25 and Declines for Decades — What the Evidence Shows

DHEA is one of the most studied anti-aging compounds in existence — with over 4,000 published studies. Here's what the RCTs actually show about who benefits, who doesn't, and how to dose it safely.

DHEA is one of the most abundant hormones in the human body — and one of the most reliably declining ones. Produced primarily in the adrenal glands, DHEA (dehydroepiandrosterone) and its sulfate form DHEA-S peak in your mid-20s and then fall steadily at roughly 2% per year. By age 70, most people have 10–20% of the DHEA levels they had at their peak.

That steep decline has made DHEA one of the most studied anti-aging compounds of the past four decades. The clinical database is massive — over 4,000 published studies, including several large randomized controlled trials. But the results are more nuanced than most supplement marketers let on.

This article covers what the evidence actually shows: when DHEA supplementation works, when it doesn’t, who benefits most, the key safety considerations, and what the research says about dosing.


What Is DHEA? A Quick Primer

DHEA is a steroid hormone produced primarily by the adrenal cortex, with smaller amounts made in the gonads and brain. It serves as the primary precursor to both androgens (testosterone, DHT) and estrogens (estradiol, estrone), making it a kind of hormonal “hub.”

In the bloodstream, most DHEA is immediately sulfated to DHEA-S — the storage form that circulates at concentrations 300–500× higher than free DHEA. When tissues need it, enzymes convert DHEA-S back to DHEA and then onward to androgens or estrogens depending on local needs.

DHEA also acts directly on receptors — including androgen receptors, sigma-1 receptors in the brain, and cell surface receptors — so it’s not purely a precursor hormone. Some of its effects appear to be independent of downstream conversion.

The Aging Decline

A landmark study by Orentreich et al. (1984) established that DHEA-S declines linearly with age starting in the late 20s. Subsequent population studies have consistently confirmed this:

  • Peak DHEA-S: typically 250–500 μg/dL (men), 150–380 μg/dL (women) in the mid-20s
  • By age 65–70: levels fall to roughly 30–100 μg/dL in both sexes
  • By age 80: some individuals show near-undetectable DHEA-S

This decline is one of the most consistent biomarkers of biological aging — more predictable than testosterone decline in men, and more universal across both sexes. Epidemiological data from the NHANES and Baltimore Longitudinal Study on Aging associate low DHEA-S with higher all-cause mortality, cardiovascular disease risk, and cognitive decline. Whether this relationship is causal or simply a marker of biological age remains the central debate.


What the Evidence Shows — By Outcome

Adrenal Insufficiency: The Clearest Indication

DHEA’s most evidence-based use is in people with primary or secondary adrenal insufficiency (Addison’s disease, hypopituitarism). In these conditions, the adrenal glands fail to produce adequate hormones — including DHEA.

Multiple RCTs have shown that DHEA replacement (typically 25–50 mg/day) in this population produces consistent improvements in:

  • Well-being and quality of life: Hunt et al. 2000 (NEJM) — 281 patients with hypopituitarism; 50 mg DHEA for 6 months significantly improved self-rated well-being, sexual function, and psychological health
  • Depression and mood: Arlt et al. 1999 — 24 women with adrenal insufficiency; DHEA significantly reduced depression and anxiety scores
  • Libido: Consistently observed across multiple RCTs in this population, particularly in women

The Endocrine Society’s clinical guidelines (2015) acknowledge DHEA replacement as reasonable in patients with documented adrenal insufficiency, especially women with sexual dysfunction or low well-being despite adequate cortisol and mineralocorticoid replacement.

Key takeaway: If you have diagnosed adrenal insufficiency, DHEA supplementation has meaningful clinical backing. This is the strongest indication in the literature.


Libido and Sexual Function

Outside of adrenal insufficiency, the sexual function data is more mixed — but still notable, particularly for women.

The DHEA-supplemented ovaries and vaginal tissue produce local androgens that support libido and tissue health. Several trials have shown benefit:

  • Intrarosa (prasterone) — FDA-approved in 2016 as a vaginal DHEA insert (6.5 mg/day) for postmenopausal dyspareunia (painful intercourse). This is a prescription-grade approval based on RCT data showing meaningful improvements in vaginal atrophy, lubrication, and pain scores
  • Labrie et al. 2015 — A 12-week RCT of 216 women; vaginal DHEA significantly improved desire, arousal, lubrication, orgasm, and satisfaction scores versus placebo
  • Oral DHEA in postmenopausal women: Effect sizes are smaller than intravaginal administration but several trials (including Panjari & Davis 2007) show modest improvements in desire and satisfaction

For men, DHEA’s effects on sexual function are largely mediated by testosterone conversion — and the data is less consistent than in women, largely because baseline testosterone matters more in men.


Bone Density

DHEA supports bone density through conversion to estrogen and testosterone, both of which are bone-protective. The evidence is most consistent in older women with low DHEA-S levels:

  • Villareal et al. 2000 (JAMA) — 60 older adults (50–65) given 50 mg/day DHEA for 6 months; significant increases in bone mineral density at the hip in women, with modest gains in men
  • Jankowski et al. 2006 — 87 women and men aged 55–75; 50 mg/day DHEA for 2 years maintained spine BMD in women and improved hip BMD versus placebo
  • A 2013 meta-analysis (Pan et al.) pooling 9 RCTs found a small but significant positive effect of oral DHEA on femoral neck BMD in women, with no significant effect in men

These are not large effect sizes. DHEA is not a substitute for established bone therapies in osteoporosis. But for older women with borderline-low DHEA-S and mild bone density concerns, there is a reasonable evidence base.


Cognitive Function and Mood

This is where the data is more complicated.

Animal studies and some observational data suggest DHEA and DHEA-S have neuroprotective properties — DHEA acts as a positive allosteric modulator of NMDA receptors and sigma-1 receptors, both involved in learning and memory. DHEA-S inhibits GABA-A receptors, with stimulatory effects on neuronal activity.

But the RCT data in humans has been disappointing:

  • Kritz-Silverstein et al. 2008 (NEJM) — 110 older adults; 50 mg/day DHEA for 2 years did not improve cognition, mood, physical performance, or quality of life compared to placebo
  • Barnhart et al. 1999 — 60 mg/day DHEA for 3 months showed no improvement in memory or cognitive function in middle-aged adults
  • Van Niekerk et al. 2001 — 100 mg/day DHEA in older men for 12 weeks; no significant cognitive benefit

Where there may be a signal: Studies specifically in people with diagnosed depression or in people with very low baseline DHEA-S show more promise: - Wolkowitz et al. 1997 (Biol Psychiatry) — 6 depressed middle-aged patients; 90 mg/day DHEA for 6 weeks; significant antidepressant response in 5 of 6 patients (small but notable) - A National Institute of Mental Health RCT (Schmidt et al. 2005) — 46 adults with midlife-onset dysthymia; DHEA 90–450 mg/day for 6 weeks significantly outperformed placebo on depression ratings

The picture: DHEA is not a general cognitive enhancer, but may have genuine antidepressant properties in specific populations with documented deficiency. If your DHEA-S is in range for your age, supplementing likely won’t move the needle cognitively.


Body Composition and Insulin Sensitivity

Several trials have investigated whether DHEA can improve body composition in older adults:

  • Villareal & Holloszy 2004 (JAMA) — 56 older adults; 50 mg/day for 6 months reduced abdominal fat (measured by CT scan) and improved insulin action. The reduction in visceral fat was significant and comparable to effects seen with some lifestyle interventions
  • Nestler et al. 1988 — Men given 1,600 mg/day DHEA for 4 weeks (a pharmacological dose) showed 31% reduction in body fat, but this dose is far above anything clinically practical
  • Meta-analyses at therapeutic doses (25–75 mg/day) show modest reductions in waist circumference and fat mass in older adults

The insulin sensitivity effect may be partly mediated by increased IGF-1 and downstream effects on muscle and fat metabolism.


7-Keto DHEA: The Variant That Doesn’t Convert to Sex Hormones

7-Keto DHEA is a naturally occurring metabolite of DHEA that does NOT convert to estrogen or testosterone. This makes it theoretically attractive for anyone who wants metabolic benefits without hormonal exposure.

The evidence for 7-Keto specifically:

  • Kalman et al. 2000 — 30 adults following a calorie-restricted diet; those taking 200 mg/day 7-Keto DHEA lost significantly more weight than placebo (6.3 lbs vs 2.2 lbs over 8 weeks). The proposed mechanism is increased thermogenesis via upregulation of T3 (triiodothyronine)
  • Zenk et al. 2002 — Similar design; 7-Keto significantly increased resting metabolic rate versus placebo in overweight adults

7-Keto is currently approved by WADA as non-anabolic (unlike DHEA, which is banned in competitive sports). It appears in thyroid-boosting and fat-burning supplement formulas. The evidence is preliminary but not without substance — particularly for the metabolic rate effect.


Dosing: What the RCTs Actually Use

Use Case Typical Dose Notes
Adrenal insufficiency (women) 25–50 mg/day Best evidence; morning dosing
Postmenopausal well-being 25–50 mg/day Take with food
Bone density support 50 mg/day 2-year trials show effect
Depression (with low DHEA-S) 90–450 mg/day Pharmacological range; medical supervision
Vaginal atrophy 6.5 mg/day intravaginal Prescription (Intrarosa)
7-Keto DHEA (metabolic) 100–200 mg/day Non-hormonal metabolite

Important note on baseline: DHEA supplementation makes most sense in people with documented low DHEA-S. If your levels are normal for your age, supplementation may push you into supraphysiological ranges, especially for testosterone/estrogen in women. Testing DHEA-S before and during supplementation is strongly recommended.


Safety and Contraindications

DHEA is generally well-tolerated at doses up to 50 mg/day in short-to-medium term trials. But there are important cautions:

Hormone-Sensitive Conditions

Because DHEA converts to both androgens and estrogens, it is contraindicated or should be used only with medical supervision in:

  • Hormone-sensitive cancers: Breast cancer, endometrial cancer, prostate cancer, ovarian cancer. DHEA may promote growth in hormone-receptor-positive tumors
  • Polycystic ovary syndrome (PCOS): Women with PCOS often already have elevated androgens — DHEA could worsen symptoms including acne, hair loss, and cycle disruption
  • BPH (benign prostatic hyperplasia): Conversion to DHT may exacerbate symptoms

Androgenic Side Effects in Women

At doses above 25 mg/day, some women experience: - Acne (oily skin) - Increased facial/body hair growth - Scalp hair thinning - Clitoral sensitivity changes

These effects are dose-dependent and largely reversible.

Drug Interactions

  • Anticoagulants (warfarin): DHEA may alter coagulation; monitor INR
  • Insulin and blood sugar medications: DHEA affects insulin sensitivity; may require dose adjustments in diabetics
  • Psychiatric medications: Given potential effects on mood and neurosteroid activity, use cautiously alongside antidepressants or anxiolytics

Liver Considerations

Some DHEA formulations (particularly unesterified oral DHEA) undergo significant first-pass hepatic metabolism. Long-term high-dose use in people with existing liver conditions warrants monitoring of liver enzymes.


Who Should Consider DHEA Supplementation?

Most likely to benefit: - Women with diagnosed adrenal insufficiency (primary or secondary) - Postmenopausal women with low libido and documented low DHEA-S - Older adults (60+) with DHEA-S below the 25th percentile for their age with concurrent bone density concerns - Adults with treatment-resistant depression and documented low baseline DHEA-S

Probably won’t benefit: - Young adults with normal DHEA-S levels for their age - Anyone seeking cognitive enhancement as the primary goal - Athletes seeking performance benefits (DHEA is banned by WADA)

Should avoid without medical supervision: - Anyone with a history of hormone-sensitive cancer - Women with PCOS - Men with active or suspected prostate issues


How DHEA Compares to Other Anti-Aging Strategies

DHEA is often marketed alongside NMN, rapamycin, and senolytic compounds as a longevity intervention. The comparison is instructive:

Compound Primary Mechanism Human RCT Evidence Who Benefits Most
DHEA Hormone precursor, direct receptor activity Strong for adrenal insufficiency; mixed otherwise Low DHEA-S adults, postmenopausal women
NMN/NR NAD+ repletion Early-stage; promising for metabolic function Adults 40+ with metabolic concerns
Urolithin A Mitophagy activation Phase II data; muscle/mitochondrial function People with poor gut microbiome diversity
Rapamycin mTOR inhibition Strong animal data; limited human longevity RCTs Unclear; being studied in older adults

DHEA’s advantage is that it targets a specific, measurable, age-related decline — and for people with genuinely low DHEA-S, the hormonal restoration effect is both predictable and meaningful. It’s not speculative in the same way that NAD+ precursors or senolytics currently are.


Testing Your DHEA-S Levels

DHEA-S is measured via a standard blood test and should be part of any serious hormonal health workup. Reference ranges vary by lab, but general adult reference ranges:

  • Men:
  • Age 20–29: 250–520 μg/dL
  • Age 40–49: 150–380 μg/dL
  • Age 60–69: 70–210 μg/dL

  • Women:

  • Age 20–29: 150–380 μg/dL
  • Age 40–49: 80–250 μg/dL
  • Age 60–69: 40–150 μg/dL

If your DHEA-S is in the lower quartile for your age group and you’re experiencing symptoms consistent with decline (fatigue, low libido, mood changes, bone loss), supplementation is worth discussing with a physician.


The Bottom Line

DHEA is the rare supplement that is both genuinely important to physiology and genuinely complicated in terms of who benefits from supplementation. The strongest evidence is for people with diagnosed adrenal insufficiency and postmenopausal women with low DHEA-S and libido concerns. For everyone else, the evidence is more conditional — useful for some outcomes (bone density, body composition, possibly mood) in people with documented deficiency, but not a universal anti-aging intervention.

Unlike most supplements where the primary downside is wasted money, DHEA carries real hormonal risks — particularly for women with androgen-sensitive conditions and anyone with a history of hormone-sensitive cancers. This is one supplement where measuring before supplementing isn’t optional — it’s essential.

If your DHEA-S levels are genuinely low, and you’re working with someone monitoring your hormone panel, there is solid clinical support for supplementation in the 25–50 mg/day range. If your levels are normal, it’s unlikely to move the needle — and could push you into ranges that create downstream problems.

For more on related hormone-adjacent supplements, see our guides on Tongkat Ali and the testosterone optimization stack.

Nathan Ellsberg
Nathan Ellsberg
MPH, Epidemiology
Nathan holds a master's in public health from Columbia with a focus on epidemiology and evidence synthesis. He specializes in critically appraising study design, effect sizes, and meta-analyses.
Fact-checked by
Dr. Carlos Vega
Dr. Carlos Vega · MD, Sports Medicine

5 Comments

Amanda L.
Amanda L. Jun 05, 2026

Followed the protocol here for 6 weeks. Noticeable difference by week 4.

Sarah Chen
Sarah Chen Jun 06, 2026

Bookmarked this. The dosing info alone saved me hours of research.

Lily Z.
Lily Z. Jun 08, 2026

The product quality section is the most practically useful thing I have read all month.

Jess T.
Jess T. Jun 12, 2026

Finally someone who distinguishes between animal studies and actual human trials.

Kevin S.
Kevin S. Jun 30, 2026

The stack suggestions at the end were exactly what I was looking for.

Leave a comment